YUPELRI
Active substance: revefenacin
SOLUTION · REVEFENACIN 175 ug/3mL
United StatesActive
Marketing holder: Viatris Specialty LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- REVEFENACIN · 175 ug/3mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-e5b8-7734-a67d-45c34f87882c;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 49502-806
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 49502-806 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 49502-806 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 49502-806 · Verified 2026-10-09 · open in source